Table 1 Age, sex and state breakdown of samples included in study
From: Seroprevalence of antibodies to primate erythroparvovirus 1 (B19V) in Australia
State | n | Age group (years) | Male (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
0–4 | 5–9 | 10–15 | 16–24 | 25–34 | 35–44 | 45–54 | 55–64 | 65–80 | |||
BLOOD DONOR | |||||||||||
 Total | 2221 | – | – | – | 374 | 376 | 376 | 376 | 367 | 352 | 49.93% |
 New South Wales | 323 | – | – | – | 54 | 54 | 54 | 54 | 54 | 53 | 49.85% |
 Northern Territory | 293 | – | – | – | 53 | 54 | 54 | 53 | 49 | 30 | 51.19% |
 Queensland | 323 | – | – | – | 53 | 54 | 54 | 54 | 54 | 54 | 50.15% |
 South Australia | 321 | – | – | – | 54 | 54 | 54 | 53 | 52 | 54 | 49.84% |
 Tasmania | 320 | – | – | – | 53 | 54 | 53 | 54 | 52 | 54 | 49.69% |
 Victoria | 317 | – | – | – | 53 | 52 | 53 | 54 | 52 | 53 | 48.90% |
 Western Australia | 324 | – | – | – | 54 | 54 | 54 | 54 | 54 | 54 | 50.00% |
PEDIATRIC | |||||||||||
 Total (Queensland only) | 223 | 69 | 88 | 66 | – | – | – | – | – | – | 49.78% |